Reversible and phorbol ester-specific defect of protein kinase C translocation in hepatocytes isolated from phenobarbital-treated rats.

Phorbol ester-induced translocation of the calcium/phospholipid-dependent protein kinase, protein kinase C (PKC), from soluble to particulate cell fractions was inhibited in primary cultures of hepatocytes isolated from rats chronically exposed to the liver tumor promoter phenobarbital (PB). Inhibition of translocation (34%) was significant after a 15-min treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA, 500 nM); an 85% inhibition was observed after 60 min. In contrast, the translocation responses to two non-phorbol ester activators of PKC, ATP (1 mM) and arginine-vasopressin (0.1 microM), were not significantly impaired. Assessment of total PKC specific activity revealed that translocation induced by TPA and the two nonphorbol activators was not associated with PKC degradation in hepatocytes from either control or PB-exposed rats. The defect in TPA-induced translocation was correlated with an impaired down-regulation of the hepatocyte surface receptor for epidermal growth factor in hepatocytes from PB-exposed rats. Chronic exposure to PB did not affect the total content or specific activity of PKC in whole liver, nor did it affect the distribution of PKC activity between soluble and particulate fractions in unstimulated liver or hepatocytes. However, both the diminished epidermal growth factor receptor response and the inhibition of TPA-induced PKC translocation were reversed by withdrawal of PB for 2 to 4 weeks. Hepatocytes isolated from female rats were found to contain a 3- to 4-fold greater PKC specific activity and content than hepatocytes from male rats. However, no sex-related differences were observed in PKC distribution or in the modulation of translocation by chronic PB exposure and withdrawal. Immunoblotting of partially purified liver extracts revealed that the defect in phorbol ester-induced translocation was not caused by altered expression of PKC isozymes. PKC isozymes II and III, but not I, were detected, and their amounts were unaffected by PB exposure, although higher levels were detected in female relative to male livers. These data demonstrate reversible inhibition of phorbol ester-induced PKC activation by the liver tumor promoter, PB, and suggest that PB alters a component of the PKC-signaling pathway other than the expression of PKC isozymes.

[1]  S. Fischer,et al.  Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C. , 1989, Cancer research.

[2]  G. Nelsestuen,et al.  Differences in the effects of phorbol esters and diacylglycerols on protein kinase C. , 1989, Biochemistry.

[3]  R. Jirtle,et al.  Independent mechanisms for tumor promoters phenobarbital and 12-O-tetradecanoylphorbol-13-acetate in reduction of epidermal growth factor binding by rat hepatocytes. , 1989, Cancer research.

[4]  R. Isseroff,et al.  Subcellular distribution of protein kinase C/phorbol ester receptors in differentiating mouse keratinocytes , 1989, Journal of cellular physiology.

[5]  S. Kaufmann,et al.  Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells , 1989, The Journal of cell biology.

[6]  K. Yanagimoto,et al.  Transmembrane signaling: tumor promoter distribution. , 1989, Biochimica et biophysica acta.

[7]  M. Houweling,et al.  Isozymic forms of protein kinase C in regenerating rat liver , 1989, FEBS letters.

[8]  Y. Nishizuka,et al.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation , 1988, Nature.

[9]  R. Davis.  Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity. , 1988, The Journal of biological chemistry.

[10]  M. Ingelman-Sundberg,et al.  Evidence for separate control by phorbol esters of CD18-dependent adhesion and translocation of protein kinase C in U-937 cells. , 1988, Cancer research.

[11]  M. Hagiwara,et al.  Cell type-specific expression of protein kinase C isozymes in the rabbit cerebellum. , 1988, The Journal of biological chemistry.

[12]  Y. Okamoto,et al.  Protein kinase C in the regenerating rat liver. , 1988, Biochemical and biophysical research communications.

[13]  R. Jirtle,et al.  Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation. , 1988, Carcinogenesis.

[14]  Y. Nozawa,et al.  Biphasic effects of 12-O-tetradecanoylphorbol-13-acetate on the cell morphology of low calcium-grown human epidermal carcinoma cells: involvement of translocation and down regulation of protein kinase C. , 1988, Cancer research.

[15]  C. Putnam,et al.  Hepatic protein kinase C: translocation stimulated by prolactin and partial hepatectomy. , 1987, Life sciences.

[16]  H. Koeffler,et al.  Effects of phorbol ester on translocation and down-regulation of protein kinase C and phosphorylation of endogenous proteins in human acute myeloid leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a. , 1987, Cancer research.

[17]  H. Pitot,et al.  Effects of tumor-promoting agents 12-O-tetradecanoylphorbol-13-acetate and phenobarbital on DNA synthesis of rat hepatocytes in primary culture. , 1987, Cancer research.

[18]  T. Starzl,et al.  Different response to epidermal growth factor of hepatocytes in cultures isolated from male or female rat liver. Inhibitor effect of estrogen on binding and mitogenic effect of epidermal growth factor. , 1987, Gastroenterology.

[19]  P. Blackshear,et al.  Immunocytochemical evidence for phorbol ester-induced directional translocations of protein kinase C in HL60, K562, CHO, and E7SKS cells: possible role in differentiation. , 1987, Cancer research.

[20]  A. Tashjian,et al.  Time-dependent changes in protein kinase C distribution and disappearance in phorbol ester-treated human osteosarcoma cells. , 1987, Cancer research.

[21]  C. McArdle,et al.  Phorbol esters reduce gonadotrope responsiveness to protein kinase C activators but not to Ca2+-mobilizing secretagogues. Does protein kinase C mediate gonadotropin-releasing hormone action? , 1987, The Journal of biological chemistry.

[22]  M. Vallotton,et al.  Identification of a Major Defect in Insulin-Resistant Tissues of Genetically Obese (fa/fa) Rats: Impaired Protein Kinase C , 1987, Diabetes.

[23]  E. Huberman,et al.  Translocation of protein kinase C in human leukemia cells susceptible or resistant to differentiation induced by phorbol 12-myristate 13-acetate. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Shoji,et al.  Immunocytochemical evidence for phorbol ester-induced protein kinase C translocation in HL60 cells. , 1986, Biochemical and biophysical research communications.

[25]  R. Evans,et al.  Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms , 1986, Cell.

[26]  M. Ingelman-Sundberg,et al.  Phorbol ester-induced alteration of differentiation and proliferation in human hematopoietic tumor cell lines: relationship to the presence and subcellular distribution of protein kinase C. , 1985, Cancer research.

[27]  P. Blackmore,et al.  Stimulation of 1,2-diacylglycerol accumulation in hepatocytes by vasopressin, epinephrine, and angiotensin II. , 1985, The Journal of biological chemistry.

[28]  G A McPherson,et al.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. , 1985, Journal of pharmacological methods.

[29]  R. W. Wrenn,et al.  Redistribution of phospholipid/calcium-dependent protein kinase and altered phosphorylation of its soluble and particulate substrate proteins in phorbol ester-treated rat pancreatic acini. , 1985, Cancer research.

[30]  Y. Nishizuka.  The role of protein kinase C in cell surface signal transduction and tumour promotion , 1984, Nature.

[31]  M. James,et al.  Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Kraft,et al.  Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane , 1983, Nature.

[33]  Y. Nishizuka,et al.  Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification, and properties. , 1982, The Journal of biological chemistry.

[34]  G. Michalopoulos,et al.  Liver regeneration studies with rat hepatocytes in primary culture. , 1982, Cancer research.

[35]  M. Houslay,et al.  Phenobarbital selectively modulates the glucagon-stimulated activity of adenylate cyclase by depressing the lipid phase separation occurring in the outer half of the bilayer of liver plasma membranes. , 1981, The Biochemical journal.

[36]  M. Shoji,et al.  Calcium-dependent protein kinase: widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin, and trifluoperazine. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[37]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[38]  A. Ullrich,et al.  Protein kinase C , 1987, Journal of cellular physiology. Supplement.

[39]  E. Farber.  Liver cell cancer: insights into the pathogenesis of hepatocellular carcinoma in humans from experimental hepatocarcinogenesis in the rat. , 1987, Monographs in pathology.

[40]  W. Anderson,et al.  Hormone- and tumor promoter-induced activation or membrane association of protein kinase C in intact cells. , 1987, Methods in enzymology.

[41]  吉川 潮.  Calcium-activated, phospholipid-dependent protein kinase from rat brain , 1984 .

[42]  J. Niedel,et al.  Phorbol diester receptor copurifies with protein kinase C. , 1983, Proceedings of the National Academy of Sciences of the United States of America.